Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
tuvusertib (M1774)
i
Other names:
M1774, M 1774
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
EMD Serono
Drug class:
ATR inhibitor
Related drugs:
‹
AZD6738 (16)
M6620 (13)
BAY 1895344 (12)
VE-821 (6)
SC0245 (2)
ATG-018 (1)
QL-VIII-58 (1)
AZD6738 (16)
M6620 (13)
BAY 1895344 (12)
VE-821 (6)
SC0245 (2)
ATG-018 (1)
QL-VIII-58 (1)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
BRCA1 mutation
Ovarian Cancer
BRCA1 mutation
Ovarian Cancer
niraparib + M1774
Sensitive: D – Preclinical
AACR 2023 - 1 week (New D)
niraparib + M1774
Sensitive
:
D
AACR 2023 - 1wk
niraparib + M1774
Sensitive: D – Preclinical
AACR 2023 - 1 week
niraparib + M1774
Sensitive
:
D
AACR 2023 - 1 week - (New D)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login